Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

192 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-09-30

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this trial is to evaluate aspects of treatment response in cocaine dependent individuals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Medications for Stopping Cocaine Dependence and Preventing Relapse

NCT00218023

Cocaine Abuse Cocaine-Related Disorders

COMPLETED PHASE2

Integrated Treatment for Cocaine and Mood Disorders - 1

NCT00227812

Cocaine Dependence Depressive Disorder, Major

COMPLETED PHASE2

Brain Function and Structure in Cocaine Dependence

NCT02080832

Cocaine Dependence

COMPLETED PHASE2

Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals

NCT00218062

Cocaine-Related Disorders

COMPLETED PHASE2

Modafinil Treatment for Cocaine-Dependent Individuals

NCT00129285

Cocaine-Related Disorders

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cocaine is a strong central nervous system stimulant that is widely abused throughout the United States. Due to its widespread use, it is important to develop an effective treatment for cocaine dependence. The purpose of this study is to determine how impulsivity and prefrontal cortical function are related to treatment response in cocaine dependent individuals.

Participants in this study will complete four separate experiments, each with a different aim and testing panel \[cognitive function tests with and without functional magnetic resonance imaging (fMRI)\]. The first experiment will examine memory, attention, cognitive function, and impulsivity; the aim is to determine the relationship between impulsivity and cognitive function in cocaine dependent individuals receiving treatment. The second experiment will examine the relationship between impulsivity and the prefrontal cortical structure and function. Participants will complete an fMRI during the second experiment. The third experiment will consist of cognitive function tests and will examine the prefrontal cortex in relation to treatment response, based on four different treatments: 1) L-dopamine, 2) naltrexone, 3) modafinil, and 4) placebo. The fourth experiment will examine the effect of cocaine dependence treatment on prefrontal cortex, focusing on participants receiving modafinil.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cocaine Abuse Cocaine-Related Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meets DSM-IV criteria for cocaine dependence

Exclusion Criteria

* Current or history of DSM-IV Axis I disorders, other than substance abuse or dependence
* Lifetime diagnosis of alcohol dependence
* Serious non-psychiatric medical illness requiring ongoing medical treatment or one that affects the central nervous system
* Positive urine drug screen test for drugs of abuse other than cocaine at the time of study entry
* AIDS-defining illness
* Intelligence Quotient (IQ) below 70
* Pregnant
* Uses a pacemaker, metal or electromechanical implants, or metallic foreign bodies

Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes